Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PEPD | P12955 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5908781 | 0.96 | LMNA (0.50) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL6070608 | 0.96 | SLC34A1 (0.61) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL8949443 | 0.93 | SLC34A1 (0.50) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL11356729 | 0.92 | LMNA (0.47) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL29077434 | 0.92 | LMNA (0.47) | SLC34A1LMNACA4KMT2AKDM4E | |
| Oxalic Acid SCHEMBL27609160 | 0.89 | SLC34A1 (0.53) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL27241883 | 0.89 | SLC34A1 (0.64) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL28557229 | 0.89 | SLC34A1 (0.53) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL28930275 | 0.89 | SLC34A1 (0.64) | SLC34A1LMNACA4KMT2AKDM4E | |
| Phosphoric Acid SCHEMBL28304761 | 0.89 | LMNA (0.44) | SLC34A1LMNACA4KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773453-A | Preparation method of high-resistance fish collagen peptide | 滨海宇美科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| EP-1857102-A1 | Folic acid supplement | Drugtech Corporation (US) | 2007-11-21 | — | — | EP | claimed |
| WO-2023110843-A1 | HETEROBICYCLIC DERIVATIVES AS ITK INHIBITORS | ALMIRALL, S.A. (ES) | 2023-06-22 | — | — | WO | disclosed |
| CN-114773453-A | Preparation method of high-resistance fish collagen peptide | 滨海宇美科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-110897111-A | Calcium alginate cold process suction jelly and preparation method thereof | 青岛明月海藻生物健康科技集团有限公司 | 2020-03-24 | — | — | CN | disclosed |
| EP-1857102-A1 | Folic acid supplement | Drugtech Corporation (US) | 2007-11-21 | — | — | EP | disclosed |
| CN-1893941-A | Fused-ring compounds and use thereof as drugs | JAPAN TOBACCO INC (JP) | 2007-01-10 | — | — | CN | disclosed |